Source: Annual Congress 2006 - Respiratory disease in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Dorinsky, S. Yancey, L. Baitinger, J. Stauffer (RTP, United States Of America). Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy?. Eur Respir J 2006; 28: Suppl. 50, 1832

Member's Comments

No comment yet.

Related content which might interest you: Do measures of bronchial responsiveness add information in diagnosis and monitoring of patients with asthma? Source: Eur Respir J 2001; 18: 439-441 Year: 2001 Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Source: Eur Respir J 2007; 30: 457-466 Year: 2007 Suppression of FENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice? Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019 Year: 2019 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies Year: 2009 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment Year: 2009 Effectiveness of different models of maintenance therapy for bronchial asthma (BA) in routine clinical practice Source: Eur Respir J 2007; 30: Suppl. 51, 70s Year: 2007 Airway inflammation in asthma: current and future targets and therapies Source: Breathe 2010; 6: 245-252 Year: 2010 Clinical use of induced sputum in the management of asthma. A noninvasive measurements of airway Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007 The usefulness of the impulse oscillometry for predicting the treatment outcomes of bronchial thermoplasty in patients with severe asthma. Source: International Congress 2018 – Asthma analysis Year: 2018 Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives Source: Eur Respir Rev 2015; 24: 594-601 Year: 2015 Bronchial hyperreactivity in asthma: relationship with clinical severity and therapy Source: Eur Respir J 2005; 26: Suppl. 49, 617s Year: 2005 How can we improve our assessment of inflammation in clinical studies of COPD that use bronchial biopsies? Source: Eur Respir J 2006; 27: 248-249 Year: 2006 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Comparative assessment of the qol specific parameters in children with bronchial asthma with standard pharmacotherapy, and in additional course of physiotherapy in the pool Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects Year: 2018 Does a correlation exist between bronchial hyperresponsiveness and therapy in asthma? Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002 Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Does satisfaction with inhaled asthma treatment correspond with spirometric parameters? Source: Eur Respir J 2006; 28: Suppl. 50, 501s Year: 2006 B2-adrenoceptor genotype16 influences airway calibre but not hyperresponsiveness in asthmatics using regular B2-agonist in addition to inhaled corticosteroids Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013